Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Leukemia

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 17 articles: HTML format

Single Articles

July 2026
1. XUE H, Hua LM, Guo M, Luo JM, et al
   [Retracted] SHIP1 is targeted by miR?155 in acute myeloid leukemia.
   Oncol Rep. 2026;56:124.
   PubMed     Abstract available
   
   
   June 2026
2. CHENG H, Zheng G, Yang Y, Xu C, et al
   Incorporating artificial intelligence into morphological diagnosis of acute leukemias: Current landscape, challenges and prospects (Review).
   Oncol Rep. 2026;55:115.
   PubMed     Abstract available
   
   
   January 2026
3. SUWANWONG Y, Ploensil P
   Role of histone deacetylases in blood cancer: Exploring peptide?based inhibitors as therapeutic strategies for leukemia treatment (Review).
   Oncol Rep. 2026;55:17.
   PubMed     Abstract available
   
   
   December 2025
4. ZHOU X, Li A, Kong D, Shi Y, et al
   The silent players: Atypical BCR?ABL isoforms as biomarkers and therapeutic hurdles in CML pathogenesis (Review).
   Oncol Rep. 2025;54:162.
   PubMed     Abstract available
   
   
   
5. JIANATI R, Chen H, Yang X, Yan L, et al
   Targeting cell death pathways in acute myeloid leukemia: Molecular mechanisms and clinical implications (Review).
   Oncol Rep. 2025;54:172.
   PubMed     Abstract available
   
   
   November 2025
6. SUN J, Huang X, Zeng X, Lei Y, et al
   DBN1?mediated upregulation of GAB2 facilitates the migration and invasion of T?cell acute lymphoblastic leukemia cells.
   Oncol Rep. 2025;54:149.
   PubMed     Abstract available
   
   
   October 2025
7. YU Y, Duan S, He J, Liang W, et al
   [Corrigendum] Highly sensitive detection of leukemia cells based on aptamer and quantum dots.
   Oncol Rep. 2025;54:129.
   PubMed     Abstract available
   
   
   September 2025
8. CHEN N, Feng L, Qu H, Lu K, et al
   [Corrigendum] Overexpression of IL?9 induced by STAT3 phosphorylation is mediated by miR?155 and miR?21 in chronic lymphocytic leukemia.
   Oncol Rep. 2025;54:107.
   PubMed     Abstract available
   
   
   August 2025
9. LI L, Gorgens A, Mussack V, Pepeldjiyska E, et al
   Role of extracellular vesicles as promotors for activation of leukemia?derived dendritic cell?mediated antileukemic immune response against AML?blasts.
   Oncol Rep. 2025;54:99.
   PubMed     Abstract available
   
   
   July 2025
10. WANG C, Yang X, Shen X, Yan S, et al
    SNX10 regulates the proliferation, apoptosis and cell cycle of acute B lymphoblastic leukemia cells via the PI3K/Akt signaling pathway.
    Oncol Rep. 2025;54:78.
    PubMed     Abstract available
    
    
    May 2025
11. QIU H, Zhang C, Ma X, Li Y, et al
    Molecular insights and treatment innovations: Advancing outcomes in acute myeloid leukemia with myelodysplasia?related changes (Review).
    Oncol Rep. 2025;53:54.
    PubMed     Abstract available
    
    
    March 2025
12. LIU YH, Zhu M, Lei PP, Pan XY, et al
    [Corrigendum] ND?09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR?ABL signaling.
    Oncol Rep. 2025;53:37.
    PubMed     Abstract available
    
    
    November 2024
13. CHEN L, Zeng P, Tang H, Chen G, et al
    Routes and molecular mechanisms of central nervous system involvement in acute myeloid leukemia (Review).
    Oncol Rep. 2024;52:146.
    PubMed     Abstract available
    
    
    August 2024
14. MORINO Y, Sugiyama H, Yamane K, Kikuchi M, et al
    Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL?60 cells.
    Oncol Rep. 2024;52:109.
    PubMed     Abstract available
    
    
    July 2024
15. IDA N, Okura M, Tanaka S, Hosono N, et al
    Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
    Oncol Rep. 2024;52:90.
    PubMed     Abstract available
    
    
    May 2024
16. TENG Z, Xu S, Lei Q
    [Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB?152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Oncol Rep. 2024;51:66.
    PubMed     Abstract available
    
    
    December 2023
17. LI J, Tang B, Miao Y, Li G, et al
    Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression.
    Oncol Rep. 2023;50:208.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum